Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 AM
Ignite Modification Date:
2025-12-24 @ 11:49 AM
NCT ID:
NCT03053661
Eligibility Criteria:
Inclusion Criteria:
* newly diagnosed patients with stage III-IVa/b head and neck squamous cell carcinoma
* fit for treatment with curative intent
* conventional primary treatment
* primary surgical treatment
* primary radiotherapeutic treatment
* informed consent
* \>18 years of age
* sufficient contraception
Exclusion Criteria:
* distant metastasis at baseline
* severe concomitant disease compromising curative treatment
* previously diagnosed other malignant diseases
* active immunosuppressive therapy
* known immune defect
* pregnancy
* anemia requiring treatment at study entry (\<9g/dl)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03053661
Study Brief:
Protocol Section:
NCT03053661